According to terms seen by Bloomberg, investors including EQT Investment, Abu Dhabi Investment Authority (ADIA), and Obag Investment sold approximately 34 million existing shares in Galderma. This latest deal marks the culmination of the process, which is the largest since Galderma's IPO on the Swiss stock exchange in 2024. The share price has nearly tripled, driven by business growth, prompting investors to capitalize on this strong performance by selling their shares gradually. Three of Galderma AG's shareholders sold their entire remaining stake of 14.3% in the Swiss skincare company in a deal valued at around 4.89 billion Swiss francs ($6.28 billion).
